These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19080757)

  • 41. Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.
    Klein P; Oloko M; Roth F; Montel V; Malerba A; Jarmin S; Gidaro T; Popplewell L; Perie S; Lacau St Guily J; de la Grange P; Antoniou MN; Dickson G; Butler-Browne G; Bastide B; Mouly V; Trollet C
    Nucleic Acids Res; 2016 Dec; 44(22):10929-10945. PubMed ID: 27507886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy.
    Müller T; Deschauer M; Kolbe-Fehr F; Zierz S
    J Neurol; 2006 Jul; 253(7):892-5. PubMed ID: 16619122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oculopharyngeal muscular dystrophy--a genetically verified taiwanese family.
    Huang CL; Wu SL; Lai SC; Lu CS; Wu-Chou YH
    Chang Gung Med J; 2010; 33(1):44-50. PubMed ID: 20184794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
    Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
    Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.
    Lin F; Yang K; Lin MT; Zheng FZ; Chen L; Ding YL; Ye ZX; Lin X; Wang N; Wang ZQ
    Ann Clin Transl Neurol; 2023 Mar; 10(3):426-439. PubMed ID: 36691350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1.
    Tavanez JP; Bengoechea R; Berciano MT; Lafarga M; Carmo-Fonseca M; Enguita FJ
    PLoS One; 2009 Jul; 4(7):e6418. PubMed ID: 19641605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.
    Malerba A; Klein P; Lu-Nguyen N; Cappellari O; Strings-Ufombah V; Harbaran S; Roelvink P; Suhy D; Trollet C; Dickson G
    Hum Mol Genet; 2019 Oct; 28(19):3301-3308. PubMed ID: 31294444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene diagnosis of oculopharyngeal muscular dystrophy in a Chinese family by a GeneScan method.
    You P; Ma Q; Tao T
    J Clin Lab Anal; 2010; 24(6):422-5. PubMed ID: 21089175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
    Raz V; Sterrenburg E; Routledge S; Venema A; van der Sluijs BM; Trollet C; Dickson G; van Engelen BG; van der Maarel SM; Antoniou MN
    BMC Neurol; 2013 Jul; 13():70. PubMed ID: 23815790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranuclear inclusions in muscle biopsy can differentiate oculopharyngodistal myopathy and oculopharyngeal muscular dystrophy.
    Ogasawara M; Eura N; Iida A; Kumutpongpanich T; Minami N; Nonaka I; Hayashi S; Noguchi S; Nishino I
    Acta Neuropathol Commun; 2022 Dec; 10(1):176. PubMed ID: 36476314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
    Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
    Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational behavior of polyalanine peptides with and without protecting groups of varying chain lengths: population of PP-II structure!
    Nandel FS; Garg ML; Shafique M
    J Mol Model; 2015 May; 21(5):123. PubMed ID: 25903302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
    Davies JE; Berger Z; Rubinsztein DC
    Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.
    Anvar SY; Raz Y; Verway N; van der Sluijs B; Venema A; Goeman JJ; Vissing J; van der Maarel SM; 't Hoen PA; van Engelen BG; Raz V
    Aging (Albany NY); 2013 Jun; 5(6):412-26. PubMed ID: 23793615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.
    Richard P; Trollet C; Gidaro T; Demay L; Brochier G; Malfatti E; Tom FM; Fardeau M; Lafor P; Romero N; Martin-N ML; Sol G; Ferrer-Monasterio X; Saint-Guily JL; Eymard B
    J Neuromuscul Dis; 2015 Jun; 2(2):175-180. PubMed ID: 27858728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.
    Robinson DO; Hammans SR; Read SP; Sillibourne J
    Hum Genet; 2005 Mar; 116(4):267-71. PubMed ID: 15645184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
    Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.
    Phillips BL; Banerjee A; Sanchez BJ; Di Marco S; Gallouzi IE; Pavlath GK; Corbett AH
    Nucleic Acids Res; 2018 Sep; 46(15):7643-7661. PubMed ID: 29939290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.